ACM
LKFT

Ativo Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Ativo Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,934
Closed -$771K – 109
2020
Q1 		$771K Buy
+3,934
New +$846K 0.48% 84

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Ativo Capital Management's LKFT Position: Q2 2020 in Review

Ativo Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2020, closing a stake of 3,934 shares — an estimated $771K sold.

Ativo Capital Management first reported a position in LKFT in Q1 2020 and held it in 1 quarter. The position peaked at $771K in Q1 2020. 143 funds tracked by Wall St. Rank hold LKFT as of Q2 2020.

  • Ativo Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • Ativo Capital Management sold 3,934 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2020, an estimated $771K.
  • Ativo Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and held it in 1 quarter.
  • Ativo Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $771K in Q1 2020.
  • 143 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2020.

Based on Ativo Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.